-
-
-
-
-
-
-
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results
-
-
-
-
-
-
-
Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
-
-
-
-
-
-
-
Labcorp (LH) Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
-
-
-
-
-
-
-
OPKO Health (OPK) Tops Q3 EPS by 12c
-
-
-
-
-
-
-
OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024
-
-
-
-
-
-
-
OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results
-
-
-
-
-
-
-
Pfizer (PFE) and OPKO (OPK) Announce FDA Approval of NGENLA
-
1,208,039 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

